{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:35:07Z","timestamp":1777620907326,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvoice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jvoice.2021.05.006","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T03:30:34Z","timestamp":1624073434000},"page":"757-763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Perception of Proton Pump Inhibitor Side Effects Among Members of the American Broncho-Esophagological Association"],"prefix":"10.1016","volume":"37","author":[{"given":"Ana\u00efs","family":"Rameau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Andreadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucian","family":"Sulica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvoice.2021.05.006_bib0001","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999\u20132012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0002","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/gast.1997.v112.pm9178669","article-title":"Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis","volume":"112","author":"Chiba","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0003","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199803123381104","article-title":"A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs. Acid suppression trial: ranitidine vs. omeprazole for NSAID-associated ulcer treatment (ASTRONAUT) study group","volume":"338","author":"Yeomans","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0004","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S2468-1253(18)30037-2","article-title":"Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials","volume":"3","author":"Scally","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124653","article-title":"Proton pump inhibitor usage and the risk of myocardial infarction in the general population","volume":"10","author":"Shah","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0006","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","article-title":"Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis","volume":"73","author":"Gomm","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0007","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjmed.2011.01.007","article-title":"Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies","volume":"124","author":"Yu","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0008","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","article-title":"Systematic review of the risk of enteric infection in patients taking acid suppression","volume":"102","author":"Leonard","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0009","doi-asserted-by":"crossref","first-page":"e0128004","DOI":"10.1371\/journal.pone.0128004","article-title":"Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis","volume":"10","author":"Lambert","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0010","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1001\/jama.2013.280490","article-title":"Proton pump inhibitor and his- tamine 2 receptor antagonist use and vitamin B-12 deficiency","volume":"310","author":"Lam","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0011","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/ki.2012.452","article-title":"Proton-pump inhibitor use is associated with low serum magnesium concentrations","volume":"83","author":"Danziger","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015735","article-title":"Risk of death among users of proton pump inhibitors: a longitudinal observational cohort study of United States veterans","volume":"7","author":"Xie","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0013","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/joim.13183","article-title":"Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID-19: a meta-analysis","volume":"289","author":"Kow","year":"2020","journal-title":"J Int Med"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0014","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/lio2.187","article-title":"Proton pump inhibitors: review of reported risks and controversies","volume":"3","author":"Brisebois","year":"2018","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0015","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of pro- ton pump inhibitors: expert review and best practice advice from the Ameri- can Gastroenterological Association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0016","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/ajg.2017.196","article-title":"No association between proton pump inhibitor use and risk of Alzheimer's disease","volume":"112","author":"Taipale","year":"2017","journal-title":"A J Gastroenterol"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0017","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1111\/jgs.14956","article-title":"Proton pump inhibitors and risk of mild cognitive impairment and dementia","volume":"65","author":"Goldstein","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0018","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/j.gastro.2017.06.061","article-title":"Association between proton pump inhibitor use and cognitive function in women","volume":"153","author":"Lochhead","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0019","doi-asserted-by":"crossref","first-page":"244","DOI":"10.14309\/ajg.0000000000000061","article-title":"Patients' perceptions of proton pump inhibitor risks and attempts at discontinuation: a national survey","volume":"114","author":"Kurlander","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/apt.15522","article-title":"Reported proton pump inhibitor side effects: what are physician and patient perspectives and behaviour patterns?","volume":"51","author":"Ghosh","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0021","article-title":"Side effects of proton pump inhibitors: what are patients\u2019 concerns?","author":"Rameau","year":"2020","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0022","doi-asserted-by":"crossref","first-page":"689","DOI":"10.14309\/ajg.0000000000000558","article-title":"Physicians' perceptions of proton pump inhibitor risks and recommendations to discontinue: a national survey","volume":"115","author":"Kurlander","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0023","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ajg.2013.69","article-title":"High economic burden of caring for patients with suspected extraesophageal reflux","volume":"108","author":"Francis","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0024","doi-asserted-by":"crossref","unstructured":"American Academy of Otolaryngology \u2013 Head and Neck Surgery. Position Statement: Laryngopharyngeal Reflux. https:\/\/www.entnet.org\/node\/928. 2002;127:32-35. Accessed December 27, 2020.","DOI":"10.1067\/mhn.2002.125760"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doy042","article-title":"Do recent reports about the adverse effects of proton pump inhibitors change providers\u2019 prescription practice?","volume":"31","author":"Al-Qaisi","year":"2018","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0026","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3928\/00989134-20190912-03","article-title":"Patient and provider perspectives on deprescribing proton pump inhibitors","volume":"45","author":"Ikeji","year":"2019","journal-title":"J Gerontol Nurs"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0027","first-page":"1","article-title":"A questionnaire on prescription patterns of proton pump inhibitors for hemodialysis patients in Japan","author":"Kawarazaki","year":"2020","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0028","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cgh.2011.11.021","article-title":"Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release","volume":"10","author":"Fass","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0029","first-page":"141","article-title":"Glad you brought it up: a patient-centred programme to reduce proton-pump inhibitor prescribing in general medical practice","volume":"20","author":"Murie","year":"2012","journal-title":"Qual Prim Care"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0030","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/fampra\/cmu050","article-title":"Strategies for discontinuation of proton pump inhibitors: a systematic review","volume":"31","author":"Haastrup","year":"2014","journal-title":"Fam Pract"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0031","doi-asserted-by":"crossref","first-page":"E539.","DOI":"10.1002\/lary.28484","article-title":"Do laryngologists and general otolaryngologists manage laryngopharyngeal reflux differently?","volume":"130","author":"Lechien","year":"2020","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0032","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/lary.27916","article-title":"Practice patterns of reflux medication prescriptions in otolaryngology compared to other specialties","volume":"130","author":"Luetzenberg","year":"2020","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0033","doi-asserted-by":"crossref","first-page":"E1589","DOI":"10.1002\/lary.29270","article-title":"Management of laryngopharyngeal reflux around the world: an international study","volume":"131","author":"Lechien","year":"2021","journal-title":"Laryngoscope"},{"issue":"9 Suppl 2","key":"10.1016\/j.jvoice.2021.05.006_bib0034","first-page":"24","article-title":"Treatment of laryngopharyngeal reflux","volume":"81","author":"Postma","year":"2002","journal-title":"Ear Nose Throat J."},{"key":"10.1016\/j.jvoice.2021.05.006_bib0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/lary.28736","article-title":"Hypopharyngeal-esophageal impedance-ph monitoring profiles of laryngopharyngeal reflux patients","volume":"131","author":"Lechien","year":"2021","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0036","first-page":"243","article-title":"Posterior pharyngolaryngitis: double-blind randomised placebo-controlled trial of proton pump inhibitor therapy","volume":"3","author":"Havas","year":"1999","journal-title":"Aust J Otolaryngol"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0037","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.mlg.0000192173.00498.ba","article-title":"Treatment of chronic posterior laryngitis with esomeprazole","volume":"116","author":"Vaezi","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0038","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1572-0241.2001.03681.x","article-title":"Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial","volume":"96","author":"El-Serag","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0039","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1097\/00005537-200112000-00013","article-title":"Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study","volume":"111","author":"Noordzij","year":"2001","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0040","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/00365520310001860","article-title":"Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study","volume":"38","author":"Eherer","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0041","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/j.1572-0241.2006.00693.x","article-title":"Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux","volume":"101","author":"Wo","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0042","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.otohns.2008.06.003","article-title":"Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux","volume":"139","author":"Reichel","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0043","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cgh.2010.03.009","article-title":"Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial","volume":"8","author":"Lam","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0044","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.otohns.2004.03.037","article-title":"Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial","volume":"131","author":"Steward","year":"2004","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.05.006_bib0045","article-title":"Review of management of laryngopharyngeal reflux disease","author":"Lechien","year":"2020","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199721001739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199721001739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:43:02Z","timestamp":1760211782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892199721001739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0892199721001739"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2021.05.006","relation":{},"ISSN":["0892-1997"],"issn-type":[{"value":"0892-1997","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perception of Proton Pump Inhibitor Side Effects Among Members of the American Broncho-Esophagological Association","name":"articletitle","label":"Article Title"},{"value":"Journal of Voice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvoice.2021.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Voice Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}